Hitchwood Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
Hitchwood Capital Management's CDNA Position: Q4 2021 in Review
Hitchwood Capital Management sold out of CareDx (CDNA) in Q4 2021, closing a stake of 250,000 shares — an estimated $15.8M sold.
Hitchwood Capital Management first reported a position in CDNA in Q4 2020 and held it in 4 quarters. The position peaked at $22.9M in Q2 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.
- Hitchwood Capital Management reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
- Hitchwood Capital Management sold 250,000 CareDx shares in Q4 2021, an estimated $15.8M.
- Hitchwood Capital Management first reported a position in CareDx in Q4 2020 and held it in 4 quarters.
- Hitchwood Capital Management's CareDx position peaked at $22.9M in Q2 2021.
- 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.
Based on Hitchwood Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.